↓ Skip to main content

Single dose oral nefopam for acute postoperative pain in adults

Overview of attention for article published in Cochrane database of systematic reviews, July 2009
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Single dose oral nefopam for acute postoperative pain in adults
Published in
Cochrane database of systematic reviews, July 2009
DOI 10.1002/14651858.cd007442.pub2
Pubmed ID
Authors

Manish Kakkar, Sheena Derry, R Andrew Moore, Henry J McQuay

Abstract

Nefopam is a centrally-acting but non-opioid analgesic drug of the benzoxazocine chemical class, developed in the early 1970s. It is widely used, mainly in European countries, for the relief of moderate to severe pain as an alternative to opioid analgesic drugs, and used in rheumatic disease and other musculoskeletal disorders in the UK. This review sought to evaluate the efficacy and safety of oral nefopam in acute postoperative pain, using clinical studies of patients with established pain, and with outcomes measured primarily over 6 hours using standard methods. This type of study has been used for many decades to establish that drugs have analgesic properties.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 16%
Student > Bachelor 6 10%
Researcher 6 10%
Other 4 7%
Student > Doctoral Student 3 5%
Other 8 14%
Unknown 22 38%
Readers by discipline Count As %
Medicine and Dentistry 17 29%
Nursing and Health Professions 7 12%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Biochemistry, Genetics and Molecular Biology 2 3%
Psychology 2 3%
Other 4 7%
Unknown 23 40%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2021.
All research outputs
#13,324,436
of 21,373,758 outputs
Outputs from Cochrane database of systematic reviews
#10,129
of 12,040 outputs
Outputs of similar age
#167,209
of 303,961 outputs
Outputs of similar age from Cochrane database of systematic reviews
#128
of 157 outputs
Altmetric has tracked 21,373,758 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,040 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.1. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 303,961 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 157 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.